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Abstract
Background and aims
Measles is an infectious disease that represents a serious public health problem worldwide,
being associated with increased susceptibility to secondary infections, especially in the
respiratory and gastrointestinal tracts. The aim of this study was to evaluate sCD163 and
sCD14 levels in measles virus (MV) infected patients, as markers of immune activation, in
order to better understand their role in the pathogenesis of the disease. TNF-α plasma levels
were also evaluated.
Methods
sCD163, sCD14 and TNF-αwere measured by ELISA in plasma samples of 27 MV infected
patients and 27 healthy donors (HD) included as controls.
Results
At the time of hospital admission, sCD163 and sCD14 levels were significantly higher in MV
infected patients than in HD, while a decrease in TNF-α levels were found even if without
statistical significance. sCD163 and sCD14 levels were significantly decreased after two
months from acute infection compared to hospital admission although they remained signifi-
cantly higher compared to HD. TNF-α levels increased significantly during the follow-up
period. Considering clinical parameters, sCD163 levels positively correlated with aspartate
aminotransferase, white blood cell count and neutrophils rate, while negatively correlated
with the lymphocyte percentage. sCD14 levels positively correlated with the neutrophil and
lymphocyte percentages.
Conclusions
These results indicate that, despite the resolution of symptoms, an important macrophage/
monocyte activation persists in measles patients, even after two months from infection.
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Introduction
Measles virus (MV) is one of the leading causes of death among young children globally, even
though a safe and cost-effective vaccine is available. In 2015, there were 134.200 measles deaths
globally, mostly children under the age of 5 years. Accelerated immunization activities have
had a major impact in reducing measles deaths, which decreased by 79% from an estimated
651.600 in 2000 to 134.200 in 2015 [1]. In 2017, there were 14.393 cases in Europe and from
December 2016 to November 2017, most of the cases were reported in Romania (41%), Italy
(35%), Germany (7%) and Greece (4%) [2]. According to the Italian National Health Institute,
there were 4885 measles cases in Italy from January 2017 to December 2017 [3].
Measles is a RNA virus of the genus Morbillivirus, subfamily Paramyxovirinae and family
Paramyxoviridae. Measles is a highly contagious disease, transmitted through direct contact
and the air. The virus infects the respiratory tract and then spreads throughout the body [4].
MV infection causes a severe but transient immunosuppression that can increase the risk of
superinfections [5]. This immune depression may last for months and is characterized by a
reduction in the number of lymphocytes both in children [6] and young adults [7]. A reduc-
tion in innate effector cells, including macrophages and natural killer cells has been described
[8] with a marked decrease in T- and B-cells especially during the acute phase of the infection
[9].
After viral clearance, lymphocyte counts tend to normalize within one week, while several
reports showed a persistent effect on the immunological status with an impairment of non-
measles memory cell repertoire [10]. Moreover, as recently reported, MV infection has been
associated also with immune activation [11]. The response to viral infection is associated with
elevated plasma levels of innate inflammatory cytokines such as tumor necrosis factor (TNF)-
α, Interleukin (IL)-1β, IL-6, and IL-18, suggesting a potential role of innate immune response
and type 1 immune activation in the pathogenesis of the disease [11].
In this study we investigated the activation of the immune system in a cohort of adult
patients with measles virus infection, by assessing the longitudinal changes of plasma levels of
soluble (s) CD163, sCD14, TNF-α at the time of hospitalization and during follow-up.
Materials and methods
Study population
The study population included a total of 27 patients with MV infection, confirmed by
the detection of MV-specific immunoglobulin (Ig)-M antibody, admitted to the Infectious
Disease Unit of the University of Rome “La Sapienza” in Latina. Twenty-seven healthy donors
(HD) with similar age and sex distribution (32, 22–65 years; 40% male) were included as
controls.
The study was approved by the local Ethics Committee CE Lazio 2 (N.0068451/2016). A
written informed consent was obtained from all participants before enrolment in the study.
All data were collected in the respect of study participants’ confidentiality and privacy.
Clinical parameters
All patients underwent a biochemical assessment to determine white blood cell (WBC) and
lymphocyte absolute count, the neutrophil and lymphocyte percentage, and platelet (PLT)
absolute count, serum levels of aspartate aminotransferase (AST), alanine aminotransferase
(ALT), gamma-glutamyl transferase (γGT), lactate dehydrogenase (LDH) and C-Reactive Pro-
tein (CRP). We also collected information on pulmonary, intestinal and liver impairment, and
the severity of mucosal involvement.
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tumor necrosis factor α.
Measles IgM Ab testing
Measles specific IgM were assessed in all serum samples using a commercial measles IgM
enzyme-linked immunosorbent assay kit (Architect Abbott).
Samples handling
A total of 54 plasma samples were collected from MV infected patients and 27 from healthy
donors. For each subject blood was collected in EDTA and heparin tubes following the manu-
facturer’s instructions, and after centrifugation plasma samples were frozen at -80˚ until use.
Plasma were collected for all patients at the time of hospital admission (T0), for 20 subjects
after 1 week (T1). For 7 patients, supplementary plasma samples were collected at 8 weeks of
follow-up (T2).
Detection of soluble biomarkers
Soluble markers of innate immune activation sCD163, sCD14 and TNF-α were detected with
commercially available ELISA kits in duplicate (Quantikine human CD163 ELISA, Quantikine
human CD14 ELISA, R&D Systems, Minneapolis, MN and LEGEND MAX™ Human TNF-α
ELISA Kit, BioLegend, San Diego, CA) as described in detail previously [12]. The limits of
detection for sCD163, sCD14 and TNF-α were 0.177 ng/ml, 0.125 ng/ml and 3.5 pg/ml
respectively.
Statistical analysis
GraphPad Prism Software version 5 (Software MacKiev) was used for statistical analysis. Val-
ues are given as median and ranges. Non-parametric Mann-Whitney test was performed to
examine the differences between healthy controls and patients and non-parametric Wilcoxon
test was used to evaluate repeated determinations of soluble markers in longitudinally collected
samples. Spearman’s correlation coefficient (r) was calculated to analyze the correlations
between inflammatory and clinical parameters. Finally, p-values less than <0.05 were consid-
ered significant.
Results
Demographic and clinical characteristics of study population
General and clinical characteristics of study subjects are listed in Table 1. No microbiologic
evidence of other viral or bacterial infections was detected. All patients were of Italian origin.
All patients were hospitalized and the median time of hospitalization was 7 days (range 4–12).
None of the patients had previously been vaccinated against measles virus. Two patients were
diabetic; 3 patients had hypertension; 22 subjects did not have any known comorbidities. The
following complications were recorded: pneumonia (8/27), keratitis (1/27), diarrhoea (12/27),
hepatitis (14/27). Moreover, 15 patients required oxygen supplementation and 6 (6/27) sub-
jects were started on systemic corticosteroids after the first blood samples was collected.
Soluble biomarkers plasma levels at the time of hospital admission
sCD163 plasma levels (median, ranges) were significantly higher in MV infected patients at
hospital admission (T0) (1011.20, 456.21–1568.43) than in HD (453.4, 279.16–810.54)
(p<0.0001) (Fig 1A). Similarly, sCD14 plasma levels were significantly higher at T0 in MV
infected patients (3614, 2280–4736) compared to HD (1365.7, 917.4–2627.4) (p<0.0001) (Fig
1B). Conversely, regarding TNF-α plasma levels, lower values were found at T0 in MV infected
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patients (16.50, 0–905) than in HD (31, 0–909) but the difference was not statistically signifi-
cant (p = 0.13) (Fig 1C).
Soluble biomarkers plasma levels during the course of follow-up
sCD163 plasma levels were persistently higher at T1 (after one week) in MV patients (1191.63,
668–1490.72) (p<0.0001). Considering a subgroup of patients who consented to have follow-
up blood samples taken after two months (T2) from the onset of symptoms (7 subjects),
sCD163 levels were decreased compared to T0 (p<0.05), although they did not reach normal
Table 1. General and clinical information of study subjects.
Characteristics MV patients
n = (27)
Age (Years) 30 (17–66)
Male/female; n (% male) 13/14 (48%)
Complications
Diabetes 2 (7%)
Hypertension 3 (11%)
O2 Sat (%) 94 (89–98)
WGBs (103/mL) 4.05 (2.3–8.9)
Lymphocytes (103/mL) 0.82 (0.23–2.5)
% neutrophils 75 (33.9–93)
% lymphocytes 18.1 (5.6–52.3)
AST level, IU/L 102 (19–885)
ALT level, IU/L 206 (14–781)
γGT level, IU/L 258 (18–766)
LDH level, IU/L 463 (213–923)
PLT (109/L) 162 (55–286)
CRP 1.75 (0.45–12.26
Results are expressed as median (range). MV: measles virus, HD: healthy donors, Sat: saturation, WGBs: white blood
cells, AST: aspartate aminotransferase, ALT: alanine aminotransferase, γGT: gamma-glutamyl transferase, LDH:
lactate dehydrogenase, PLT, platelets, CRP: C-Reactive Protein.
https://doi.org/10.1371/journal.pone.0198174.t001
Fig 1. Plasma levels of sCD163, sCD14 and TNF-α in MV infected patients and healthy controls. (A) Box plots represent circulating levels of sCD163 in MV infected
patients at T0 (n = 27) and in HD (n = 27). (B) Box plots represent circulating levels of sCD14 in MV infected patients at T0 (n = 27) and in HD (n = 27). (C) Box plots
represent circulating levels of TNF-α in MV infected patients at T0 (n = 27) and in HD (n = 27). Horizontal bars represent the median values. For TNF-α graph a log10
scale was used. Statistical differences were assessed by the Mann-Whitney test. MV: measles virus; HD: healthy donors.
https://doi.org/10.1371/journal.pone.0198174.g001
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values and remained significantly higher than in HD (p = 0.0064) (Fig 2A). Furthermore,
sCD14 plasma levels at T1 (2389, 1633–3688) were decreased compared to T0, although
they remained persistently higher than HD (p<0.0001). At T2, considering the same subgroup
of 7 patients, sCD14 levels were significantly lower compared to T0 (2392, 2042–2716)
(p = 0.01), with no relevant differences compared to T1, but remained significantly higher
than in HD (p = 0.0016) (Fig 2B). Regarding TNF-α plasma levels were significantly lower at
T0 (16.50, 0–905) than T1 (28, 0–1035) and T2 (34, 16–505) (p = 0.03 and p = 0.04 respec-
tively) (Fig 2C).
Soluble markers, demographic and clinical parameters
Considering demographic and clinical parameters sCD163 levels positively correlated with
aspartate transaminase (AST) values at T0 (r = 0.5; p = 0.009), suggesting an association with
liver damage. After stratifying patients according to alanine transaminase (ALT) levels into
two groups, one with elevated ALT and one with normal ALT, the first group had significantly
higher sCD163 levels, compared to the latter (p = 0.013). Considering TNF-α plasma levels, a
strong positive correlation with CRP values was found (r = 0.7; p = 0.006). Moreover, we
found higher sCD163 levels in patients with diarrhoea and higher TNF-α levels in patients
with respiratory failure, although this findings did not reach the statistical significance. No dif-
ferences were found in other clinical parameters, such as exanthema extension. A positive cor-
relation between sCD14 levels and the rate of both T-lymphocytes (r = 0.4; p = 0.01) and
neutrophils (r = 0.4; p = 0.01) was found. Furthermore, higher levels of sCD14 levels were
found in patients with respiratory failure, even though this finding did not reach the statistical
significance. Considering demographic parameters, no significant differences were found
between men and women, and between patients older and younger than 30 years. No changes
in the results were observed after the exclusion of 5 patients with comorbidities, suggesting the
absence of a contribution of comorbidities in changes in inflammatory markers. An accurate
statistical analysis was also performed to evaluate the influence of steroid use on sCD63 plasma
levels in the longitudinal evaluation: after exclusion of 6 patients who were treated with ste-
roids, no changes in the results were observed (S1 Fig). All correlations between soluble bio-
markers and clinical parameters are listed in Table 2.
Fig 2. Longitudinal plasma levels of sCD163, sCD14 and TNF-α in MV infected patients and in HD. (A) Box plots represent circulating levels of sCD163 in MV
infected patients at T0 (n = 27), T1 (n = 20), T2 (n = 7) and in HD (n = 27). (B) Box plots represent circulating levels of sCD14 in MV infected patients at T0 (n = 27), T1
(n = 20), T2 (n = 7) and in HD (n = 27). (C) Box plots represent circulating levels of TNF-α in MV infected patients at T0 (n = 27), T1 (n = 20), T2 (n = 7) and in HD
(n = 27). Horizontal bars represent the median values. For TNF-α graph a log10 scale was used. Statistical differences were assessed by the Mann-Whitney and Wilcoxon
tests. MV: measles virus; HD: healthy donors; T0: time of admission; T1: after 1 week; T2: 8 weeks of therapy.
https://doi.org/10.1371/journal.pone.0198174.g002
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Discussion
In the present study, we assessed monocytes/macrophages activation biomarkers in adult
patients with MV infection by evaluating plasma levels of sCD163, sCD14 and TNF-α during
both the acute and recovery stages of the infection. Our data showed that MV infection is asso-
ciated with an increase in inflammatory biomarkers in adult patients, which persists for several
weeks after recovery from the disease. Several studies described a condition of immune sup-
pression, immediately after MV infection, which represents a major cause of increased risk of
secondary infections and complications. During the acute phase of measles infection,
Table 2. Correlations between clinical and immunological parameters.
Variable sCD163 sCD14 TNF-α
Age
r 0.02 -0.04 0.1
P 0.9 0.83 0.59
WGBs
r 0.25 -0.02 -0.3
P 0.2 0.9 0.07
AST
r 0.5 0.27 -0.3
P 0.009 0.18 0.12
ALT
r 0.36 0.25 -0.3
P 0.07 0.21 0.15
γGT
r 0.37 0.29 -0.04
P 0.058 0.14 0.86
LDH
r 0.28 0.34 -0.23
P 0.16 0.088 0.27
Lymphocytes
r -0.2 -0.3 0.07
P 0.19 0.078 0.7
% neutrophils
r 0.29 0.4 -0.06
P 0.13 0.01 0.7
% lymphocytes
r -0.3 -0.4 0.13
P 0.13 0.01 0.5
PLT
r 0.21 -0.2 -0.17
P 0.29 0.22 0.40
CRP
r -0.3 0.2 0.7
P 0.34 0.47 0.006
Spearman’s correlation coefficients (r) and level of statistical significance (P) are indicated. WGBs: white blood cells,
AST: aspartate aminotransferase, ALT: alanine aminotransferase, GγGT: gamma-glutamyl transferase, LDH: lactate
dehydrogenase, PLT: platelets, CRP: C-Reactive Protein.
https://doi.org/10.1371/journal.pone.0198174.t002
High innate immune response during measles
PLOS ONE | https://doi.org/10.1371/journal.pone.0198174 May 24, 2018 6 / 11
lymphocytes can show phenotypic and numeric alterations with increased susceptibility to
apoptosis [13]. Specifically, circulating blood leukocytes are more susceptible to apoptosis
because of an increase in the expression of Fas and subsequent binding of annexin-V. Acute
phase is followed by a recovery phase in which a rapid normalization of cell counts is usually
experienced [6].
During the acute phase of MV infection, the peak of viremia is associated with a marked
reduction of T- and B-cell counts, as showed by de Vries RD et al. [9]. The subsequent expan-
sion of specific cell-mediated and humoral response leads to the control of MV replication and
the resolution of the disease [14]. However, the restoration of normal lymphocyte cell counts
does not coincide with a complete normalization of the immunological responsiveness. Some
observations showed a reduced capacity to respond to other pathogens, up to 3 years after MV
infection, thus suggesting T cell functional impairment [15]. Conversely, high T proliferative
responses have been documented in vivo [9]. An “immune amnesia” has been proposed by De
Vries et al. [9] to explain the simultaneous immune suppression and immune activation
induced by MV, with loss of memory T cell specific for non-measles pathogens and expansion
of measles specific T lymphocytes. Interestingly, a higher mortality over a period of three years
after MV infection has been described in children, suggesting a persistent effect on the
immune system [16]. Recently a pivotal role of macrophage and innate immunity has been
described in children in the context of acute MV infection, during which immunosuppression
is accompanied by a cytokine storm [11]. The main cellular receptor for MV has been identi-
fied in CD150 (also known as SLAMF1), which is expressed on B- and T-lymphocytes, den-
dritic cells and monocytes [17–19]. Alveolar macrophages and CD11c+ dendritic cells seem to
be the “early target cells” [20–22].
The first result of our study was the increased production of sCD163 and sCD14 during the
acute phase of MV infection in patients compared to healthy donors, indicating an activation
of monocyte/macrophage system. CD163 is an important surface marker expressed on mono-
cyte-macrophage lineage cells and shed in the soluble form during inflammation. Recently
increased plasma levels of sCD163 have been found in several infections (HIV, HIV/CMV
coinfection, hepatitis, sepsis, tuberculosis) and have been associated with higher risk of inflam-
mation and organ diseases, such as diabetes, obesity, atherosclerosis and liver impairment
[12,23–27]. In our study, we found higher levels of sCD163 in MV infected patients at hospital
admission compared to HD, suggesting that immune activation was present in parallel with
immune suppression. After one week, we observed persistently elevated plasma levels, while
after two months sCD163 levels significantly decreased in a subgroup of 7 patients compared
to T0, but remained significantly higher than in HD. As suggested by Esolen LM et al., mono-
cyte/macrophages represent primary target cells for MV during the acute phase of the infec-
tion in humans [28]. Indoh T et al. observed that human monocytic cell lines are persistently
infected with measles virus and their ability of producing cytokines after lipopolysaccharide
(LPS)-stimulation was significantly impaired [29].
Similar results were obtained for sCD14, the soluble form of a glycosyl phosphatidyl inosi-
tol, which is expressed mainly on monocytes, macrophages and dendritic cells and is released
upon monocyte activation. In our study population, we found a significant increase of sCD14
in MV patients at the time of hospital admission compared to HD. Conversely sCD14 plasma
levels at T1 decreased significantly compared to T0 but remained significantly higher than in
HD. After two months sCD14 levels were significantly decreased compared to T0 in the same
subgroup of 7 patients as previously described for sCD163. Despite a decrease in concentra-
tions, sCD14 levels did not reach normal values and remained significantly higher than in HD.
These results reflect a severe and long lasting immune activation. Recently, the evolution of T
cell responses in MV-infected rhesus macaques was monitored for a period of six months and
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a prolonged presence of viral RNA in PBMC was observed [30]. These data confirmed previ-
ous reports showing a delayed clearance of MV-RNA in both naturally infected children [31]
and rhesus macaques [32]. MV infects several cell types, such as lymphocytes, monocyte/mac-
rophages, epithelial cells and endothelial cells [28,33]. sCD14 and sCD163 are associated with
the innate immune response and are produced following the infection of target cells, such as
monocytes and tissue macrophages. In our study the persistently incresed levels of soluble fac-
tors of monocyte/macrophage activation could be linked to a persistent exposure to MV, sec-
ondary to a delayed viral clearance, with prolonged activation of these cell subsets.
In addition, the intestine represents an important site of MV persistence, with relevant anti-
genic stimulation, as suggested by Lewin J et al. [34]. MV persistence in the gut could lead to
deterioration of the mucosal barrier integrity with subsequent bacterial translocation. In this
context, bacterial translocation could explain the significant and persistent immune activation
of monocyte/macrophages, leading to long lasting release of soluble factors. Moreover, several
chronic diseases have been linked with MV persistence in target tissues, such as Crohn’s dis-
ease [34–35].
In our study, we did not find a statistically significant differences in TNF-α plasma levels in
MV infected patients at hospital admission compared to HD. Conversely, after one week, and
after two months an increase in TNF-α plasma levels was observed, suggesting a recovery of
TNF-α production after MV infection, whereas sCD163 and sCD14 persisted increased. Inter-
estingly, Leopardi et al. showed a reduced production of TNF-α by both MV infected periph-
eral blood monocytes and human monocytic THP-1 cell line [36]. Despite this in vitro
evidence, in vivo data are limited and are available only for children. Lin et al. showed higher
TNF-α plasma levels in MV infected children with deadly disease or HIV-infection [11]. These
data cannot be directly compared with our data, obtained from a cohort of adults, in which
plasma TNF-α seems to play a marginal role.
The limitations of the study are the lack of MV-RNA detection and quantification, the
small number of plasma samples available at 8 weeks of follow-up, and the relatively short
observation time after acute measles infection. Moreover, almost all patients presented compli-
cated MV infection, limiting the possibility to find significant differences between complicated
and uncomplicated disease.
In conclusion, our results suggest that MV infection is associated with marked and persis-
tent monocyte/macrophage activation, characterized by increased sCD163 and sCD14 levels
in plasma, even several weeks after disease recovery. A longer follow-up and a wider study
population are needed in order to define how long the immune activation state persists and
better understand the clinical significance of soluble markers elevation, which could be
employed for identifying those patients with an enhanced risk of developing long term
complications.
Supporting information
S1 Fig. Longitudinal plasma levels of sCD163 in all MV infected patients and in MV
infected patients excluding patients treated with steroids. (A) Box plots represent circulat-
ing levels of sCD163 in all MV infected patients at T0 (n = 27), T1 (n = 20), T2 (n = 7) and in
HD (n = 27). (B) Box plots represent circulating levels of sCD163 in MV infected patients
excluding patients who were treated with steroids at T0 (n = 21), T1 (n = 16), T2 (n = 5) and in
HD (n = 27). Horizontal bars represent the median values. Statistical differences were assessed
by Mann-Whitney. T0: time of admission; T1: after 1 week; T2: 8 weeks of therapy; HD:
healthy donors.
(TIF)
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